The COVID-19 pandemic highlighted the importance of collaboration, data sharing, and scientific innovation. To help researchers better understand SARS-CoV-2, the virus that causes COVID-19, the California Institute for Regenerative Medicine (CIRM) and the Chan Zuckerberg Initiative (CZI) launched a new partnership to share single-cell research data. The collaboration aims to speed scientific discovery and support … Continue reading CIRM and Chan Zuckerberg Initiative Partner to Advance COVID-19 Research
Dr. Justin Ichida
CIRM Board Approves Clinical Trials Targeting COVID-19 and Sickle Cell Disease
Coronavirus particles, illustration. Today the governing Board of the California Institute for Regenerative Medicine (CIRM) approved new clinical trials for COVID-19 and sickle cell disease (SCD) and two earlier stage projects to develop therapies for COVID-19. Dr. Michael Mathay, of the University of California at San Francisco, was awarded $750,000 for a clinical trial testing … Continue reading CIRM Board Approves Clinical Trials Targeting COVID-19 and Sickle Cell Disease
Scientists at USC untangle the mysteries of cellular reprogramming- a method that could be used to treat diseases
Dr. Justin Ichida, Assistant Professor at USC and lead author of the study Scientists have long tried to repurpose cells in order to potentially treat various types of conditions. This process, called reprogramming, involves changing one type of cell into another, such as a blood cell into a muscle cell or nerve cell. Although the … Continue reading Scientists at USC untangle the mysteries of cellular reprogramming- a method that could be used to treat diseases